ABBV vs UTHR · P/E 81, rev $16.99B vs P/E 20, rev $1.56B
AbbVie Inc (ABBV) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported ABBV revenue for 2026-06-30 was $16.99B. Net income was $3.61B. Revenue was up 13.3% from 2026-03-31 to 2026-06-30. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported UTHR revenue for 2026-06-30 was $1.56B. Net income was $607.9M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the ABBV and UTHR stock pages for the full models.
Not investment advice.